Jessica McQueary
Obstetrics & Gynecology · Billings, MTNPI 1013572973
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (49.7%), speaking fees and education — rather than concentrated in one kind of arrangement. AstraZeneca accounts for 62.7% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2023 at $1,428 and has fallen 76.5% since, to $336 in 2025.
Across 27 payments — averaging $105.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$2K
- Myriad Genetic Laboratories, Inc.$389
- Seagen Inc.$246
- GSK$214
- Foundation Medicine, Inc.$70
- Merck$63
- plus $76 from 3 others
What the payments were for
- Speaking & faculty fees$1,30046%
- Food & beverage$1,41150%
- Education$1264%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 11 | $1,778 |
| Myriad Genetic Laboratories, Inc. | 4 | $389 |
| Seagen Inc. | 3 | $246 |
| GSK | 2 | $214 |
| Foundation Medicine, Inc. | 1 | $70 |
| Merck | 3 | $63 |
| Caris MPI, Inc. | 1 | $38 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $21 |
| Pfizer | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,837 in reported general payments places this provider in the 75th percentile of 95 obstetrics & gynecology providers in Montana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Letrozole | 24 | $327 |
| Ibuprofen | 18 | $84 |
| Oxycodone Hcl | 13 | $43 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Billings
- James MetherellBillings$6K
- Rindo SironiBillings$5K
- Pamela Frederick TempletonBillings$5K
- Natalie EgglestonBillings$5K
- Jennifer ThompsonBillings$4K
- Kari BatesBillings$3K
- Michelle MontvilleBillings$3K
- Chad AbbeyBillings$838
- Douglas NeuhoffBillings$795
- Julianna PapezBillings$774
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.